摘要 |
<p>A method for inhibiting casein kinase Iεactivity, comprising administering to said patient a therapeutically effective amount of a compound of formula I. its stereoisomer, enantiomer, racemate, tautomer or pharmaceutically acceptable salt thereof.</p> |